PMID- 24326530 OWN - NLM STAT- MEDLINE DCOM- 20141007 LR - 20220318 IS - 1573-6903 (Electronic) IS - 0364-3190 (Linking) VI - 39 IP - 2 DP - 2014 Feb TI - 1-Methyl-4-phenylpyridinium-induced cell death via autophagy through a Bcl-2/Beclin 1 complex-dependent pathway. PG - 225-32 LID - 10.1007/s11064-013-1208-8 [doi] AB - Several lines of evidence suggest that the mechanism underlying drug-induced neuronal apoptosis is initiated by the increased production of reactive oxygen species (ROS). 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a neurotoxin, has been shown to initiate an apoptotic cascade by increasing ROS in the dopaminergic neurons of the substantia nigra, leading to the morphological and physiological features associated with Parkinson's disease. Recently, it has been reported that autophagy, a type of programmed cell death independent of the apoptotic cascade, also plays a role in neuronal damage. Although autophagy is negatively regulated by the mammalian target of rapamycin receptor (mTOR), there is some evidence showing a novel function for the anti-apoptotic protein Bcl-2. Bcl-2 is proposed to play a role in negatively regulating autophagy by blocking an essential protein in the signaling pathway, Beclin 1. Nevertheless, it is unclear whether autophagy is also correlated with apoptotic signaling in 1-methyl-4-phenylpyridinium (MPP(+)) toxicity. Therefore, we hypothesized that the MPP(+) toxicity generally associated with initiating the apoptotic signaling cascade also increases an autophagic phenotype in neuronal cells. Using the SK-N-SH dopaminergic cell lines, we demonstrate that MPP(+) increases the expression of microtubule-associated protein light chain 3 (LC3-II), an autophagosome membrane marker and the mTOR signaling pathway, and Beclin 1 while decreasing the Bcl-2 levels. Moreover, these expressions correlate with a decreased binding ratio between Bcl-2 and Beclin 1, in effect limiting the regulation of the downstream autophagic markers, such as LC3-II. Our results indicate that MPP(+) can induce autophagy in SK-N-SH cells by decreasing the Bcl-2/Beclin 1 complex. FAU - Nopparat, Chutikorn AU - Nopparat C AD - Research Center for Neuroscience, Institute of Molecular Biosciences, Mahidol University, Nakornpathom, Thailand. FAU - Porter, James E AU - Porter JE FAU - Ebadi, Manuchair AU - Ebadi M FAU - Govitrapong, Piyarat AU - Govitrapong P LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20131211 PL - United States TA - Neurochem Res JT - Neurochemical research JID - 7613461 RN - 0 (Apoptosis Regulatory Proteins) RN - 0 (BECN1 protein, human) RN - 0 (Beclin-1) RN - 0 (Membrane Proteins) RN - 0 (Proto-Oncogene Proteins c-bcl-2) RN - 0 (Reactive Oxygen Species) RN - 9P21XSP91P (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/*pharmacology MH - Apoptosis Regulatory Proteins MH - Autophagy/*drug effects MH - Beclin-1 MH - Blotting, Western MH - Cell Death/*drug effects MH - Cell Line, Tumor MH - Fluorescent Antibody Technique MH - Humans MH - Membrane Proteins MH - Oxidative Stress MH - Proto-Oncogene Proteins c-akt/metabolism MH - Proto-Oncogene Proteins c-bcl-2/*metabolism MH - Reactive Oxygen Species/metabolism MH - Substantia Nigra/cytology/drug effects/metabolism MH - TOR Serine-Threonine Kinases/metabolism EDAT- 2013/12/12 06:00 MHDA- 2014/10/08 06:00 CRDT- 2013/12/12 06:00 PHST- 2013/07/15 00:00 [received] PHST- 2013/11/25 00:00 [accepted] PHST- 2013/10/29 00:00 [revised] PHST- 2013/12/12 06:00 [entrez] PHST- 2013/12/12 06:00 [pubmed] PHST- 2014/10/08 06:00 [medline] AID - 10.1007/s11064-013-1208-8 [doi] PST - ppublish SO - Neurochem Res. 2014 Feb;39(2):225-32. doi: 10.1007/s11064-013-1208-8. Epub 2013 Dec 11.